Latest News

Up 200% year to date, this AI cryptocurrency could skyrocket even higher in 2027.

A SpaceX-Tesla merger would be the ultimate growth trap for retail investors.

Is Bitcoin really digital gold? Investors are about to find out.

Investors may not like what they see when they learn the sources of much of Nvidia's revenue growth.

Five quantum stocks are moving from lab promises to public balance sheets, and here is what to watch in each one heading into 2027.

PayPal is cheap, but does it make the stock a buy?

V.F. (NYSE:VFC) reported second-quarter fiscal 2027 revenue growth of 1%, exceeding its guidance for flat sales, as gross-margin expansion and lower interest expense helped drive a more than 40% increase in adjusted earnings per share. President and CEO Bracken Darrell said the company generated op

Zurn Elkay Water Solutions Cor (NYSE:ZWS) reported third-quarter sales growth and higher profitability, while raising its full-year adjusted EBITDA outlook and outlining plans to expand its commercial hot water portfolio. Third-quarter sales totaled $495 million, up 9% year over year on a reported

Usio (NASDAQ:USIO) outlined growth across its payment processing, ACH, card issuing and print-and-mail operations, while highlighting new opportunities in business banking, education disbursements and utility payments. Chief Executive Officer Louis Hoch said the fintech payment processor supports m

Stellantis (NYSE:STLA) reported third-quarter results that improved from a year earlier despite lower planned production volumes, raw-material inflation and continued pricing pressure in Europe, while reaffirming its 2026 outlook and its expectation to generate positive industrial free cash flow in

Urban Edge Properties (NYSE:UE) reported third-quarter results that included higher funds from operations, continued same-property net operating income growth and an increased full-year outlook, while outlining a strategy to recycle capital into higher-growth shopping centers and expand selectively

Universal Health Services (NYSE:UHS) reported third-quarter adjusted earnings per share of $5.22, down 8% from a year earlier, as the company cited favorable acute-care demand, improving behavioral-health volumes and moderating labor pressures but said results fell below its internal expectations af

Parsons (NYSE:PSN) reported third-quarter 2026 results that management said exceeded its commitments for revenue, adjusted EBITDA, adjusted EBITDA margin and operating cash flow, while highlighting strong contract awards and a record backlog. Total revenue rose 2% year over year, while revenue excl

ProPetro (NYSE:PUMP) reported higher third-quarter revenue, net income and adjusted EBITDA as increased completions activity and growth at its PROPWR power-generation business offset elevated costs tied to rebuilding frac capacity. Total revenue rose 16% sequentially to $355 million in the third qu

Raymond James Financial (NYSE:RJF) reported record fourth-quarter and fiscal 2026 results, extending its streak of record annual performance to six consecutive years as growth in its Private Client Group, investment banking and bank lending supported revenues and profitability. For the fiscal fourt

STAG Industrial (NYSE:STAG) reported third-quarter 2026 Core FFO of $0.66 per share, up 1.5% from a year earlier, as the industrial real estate owner cited improving operating fundamentals, strong leasing spreads and lower-than-expected credit losses. Chief Executive Officer Bill Crooker said natio

The path for Revolution Medicines to grow an initial investment of $25,000 into $1 million is a daunting one.

Data centers need more electricity, and these two providers are well positioned to benefit.

Should investors follow Wood's lead with this eVTOL manufacturer?

Moderna shares have outperformed tech giants this year.

Biotech company Regeneron (NASDAQ:REGN) will be announcing earnings results tomorrow before market hours. Here’s what investors should know. Regeneron beat a...

Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting earnings tomorrow before market open. Here’s what to expect. AbbVie beat analysts’ revenue expect...

The Federal Reserve’s preferred inflation gauge appears to be headed in the wrong direction.